Contact dermatitis from pyrrolnitrin.
D000935:Antifungal Agents / Q000009:adverse effects*; D003877:Dermatitis, Contact / Q000209:etiology* / Q000473:pathology; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007223:Infant; D011764:Pyrrolnitrin / Q000009:adverse effects* / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D014005:Tinea / Q000188:drug therapy
D000935:Antifungal Agents; D011764:Pyrrolnitrin